PMID Title Journal Publication Year Author View in RVdb
30844608 New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling. Eur J Med Chem 2019 Kassem AF;Batran RZ;Abbas EMH;Elseginy SA;Shaheen MNF;Elmahdy EM View More
32313408 Discovery of anti-SARS coronavirus drug based on molecular docking and database screening. Chin J Chem 2004 Chen HF;Yao JH;Sun J;Li Q;Li F;Fan BT;Yuan SG View More
33713730 Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Res 2021 Milani M;Donalisio M;Bonotto RM;Schneider E;Arduino I;Boni F;Lembo D;Marcello A;Mastrangelo E View More
33932782 Sub-structure-based screening and molecular docking studies of potential enteroviruses inhibitors. Comput Biol Chem 2021 James SA;Yam WK View More
34708566 Discovery of Inhibitors for Mycobacterium Tuberculosis Peptide Deformylase Based on Virtual Screening in Silico. Mol Inform 2022 Li X;Jiang Q;Yang X View More
34821198 In silico screening and covalent binding of phytochemicals of Ocimum sanctum against SARS-CoV-2 (COVID 19) main protease. J Biomol Struct Dyn 2023 Mohapatra PK;Chopdar KS;Dash GC;Mohanty AK;Raval MK View More
35165507 Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. Int J Med Sci 2022 Li J;Zhang K;Bao J;Yang J;Wu C View More
35625804 Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease. Biomedicines 2022 Gambacorta N;Caputo L;Quintieri L;Monaci L;Ciriaco F;Nicolotti O View More